These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 17899014

  • 21. Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.
    Fischetti C, Camarda V, Rizzi A, Pelà M, Trapella C, Guerrini R, McDonald J, Lambert DG, Salvadori S, Regoli D, Calo' G.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):50-7. PubMed ID: 19445927
    [Abstract] [Full Text] [Related]

  • 22. The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
    Brookes ZL, Stedman EN, Brown NJ, Hebbes CP, Guerrini R, Calo G, Reilly CS, Lambert DG.
    PLoS One; 2013 Jul 01; 8(9):e74943. PubMed ID: 24086402
    [Abstract] [Full Text] [Related]

  • 23. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation.
    Trombella S, Vergura R, Falzarano S, Guerrini R, Calo G, Spisani S.
    Peptides; 2005 Aug 01; 26(8):1497-502. PubMed ID: 15922491
    [Abstract] [Full Text] [Related]

  • 24. In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH (2).
    Kitayama M, McDonald J, Barnes TA, Calo' G, Guerrini R, Rowbotham DJ, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug 01; 375(6):369-76. PubMed ID: 17598088
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 01; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 26. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
    Sinchak K, Romeo HE, Micevych PE.
    J Comp Neurol; 2006 May 10; 496(2):252-68. PubMed ID: 16538678
    [Abstract] [Full Text] [Related]

  • 27. Structure-activity studies on high affinity NOP-active hexapeptides.
    Judd AK, Tuttle DJ, Jones RW, Sanchez A, Polgar W, Berzetei-Gurske I, Toll L.
    J Pept Res; 2004 Sep 10; 64(3):87-94. PubMed ID: 15317498
    [Abstract] [Full Text] [Related]

  • 28. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S, Camarda V, Rizzi A, Marzola G, Salvadori S, Marzola E, Molinari P, McDonald J, Ko MC, Lambert DG, Calo' G, Guerrini R.
    Br J Pharmacol; 2013 Jan 10; 168(1):151-62. PubMed ID: 22827708
    [Abstract] [Full Text] [Related]

  • 29. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
    Olianas MC, Concas D, Onali P.
    Br J Pharmacol; 2006 Feb 10; 147(4):360-70. PubMed ID: 16402046
    [Abstract] [Full Text] [Related]

  • 30. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H, Calo' G, Albrecht E, Guerrini R, Bienert M.
    J Pharmacol Exp Ther; 2000 Aug 10; 294(2):428-33. PubMed ID: 10900215
    [Abstract] [Full Text] [Related]

  • 31. Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.
    Guerrini R, Marzola E, Trapella C, Pacifico S, Cerlesi MC, Malfacini D, Ferrari F, Bird MF, Lambert DG, Salvadori S, Calo G.
    Bioorg Med Chem; 2015 Apr 01; 23(7):1515-20. PubMed ID: 25716007
    [Abstract] [Full Text] [Related]

  • 32. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.
    Green MK, Devine DP.
    Neuropeptides; 2009 Dec 01; 43(6):507-14. PubMed ID: 19720395
    [Abstract] [Full Text] [Related]

  • 33. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 01; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 34. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.
    Economidou D, Hansson AC, Weiss F, Terasmaa A, Sommer WH, Cippitelli A, Fedeli A, Martin-Fardon R, Massi M, Ciccocioppo R, Heilig M.
    Biol Psychiatry; 2008 Aug 01; 64(3):211-8. PubMed ID: 18367152
    [Abstract] [Full Text] [Related]

  • 35. Activities of mixed NOP and mu-opioid receptor ligands.
    Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, Khroyan TV, Husbands SM, Lewis JW, Toll L, Zaveri NT.
    Br J Pharmacol; 2008 Feb 01; 153(3):609-19. PubMed ID: 18059322
    [Abstract] [Full Text] [Related]

  • 36. Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation.
    Basso M, Risse PA, Naline E, Calo G, Guerrini R, Regoli D, Advenier C.
    Peptides; 2005 Aug 01; 26(8):1492-6. PubMed ID: 16042989
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M, Stocchi S, Paganini F, Mela F, De Risi C, Calo' G, Guerrini R, Barnes TA, Lambert DG, Beani L, Bianchi C, Morari M.
    Br J Pharmacol; 2003 Jan 01; 138(1):91-8. PubMed ID: 12522077
    [Abstract] [Full Text] [Related]

  • 38. Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig.
    McLeod RL, Jia Y, Fernandez X, Parra LE, Wang X, Tulshian DB, Kiselgof EJ, Tan Z, Fawzi AB, Smith-Torhan A, Zhang H, Hey JA.
    Pharmacology; 2004 Jul 01; 71(3):143-9. PubMed ID: 15161996
    [Abstract] [Full Text] [Related]

  • 39. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.
    J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186
    [Abstract] [Full Text] [Related]

  • 40. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC, Chuang KC, Wichmann J, Adam G.
    J Pharmacol Exp Ther; 2004 Nov 10; 311(2):645-51. PubMed ID: 15254141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.